found that after APS treatment, the expression of LC3B-II/I was significantly increased in colorectal cancer HCT-116 cells, while the expression levels of p-PI3K/PI3K, p-AKT/AKT, p-mTOR/mTOR, and p62 were significantly decreased (168). This evidence concerns the gene MTOR and colorectal cancer.